|
|
|
51-200 employees
View all
|
|
medical device
|
|
7545 Irvine Center Drive,Irvine,CA,US
|
|
JenaValve Technology, Inc., with locations in Irvine, Calif., Leeds, U.K. and Munich, Germany, develops and manufactures transcatheter aortic valve replacement (TAVR) systems to treat patients suffering from aortic valve disease. The Company is in clinical development of its next-generation transfemoral TAVR system in both the U.S. and CE mark countries for treating patients with aortic stenosis and/or aortic regurgitation. In addition to Bain Capital Life Sciences, JenaValve is backed by European and Asian investors, including Andera Partners (formerly Edmond de Rothschild Investment Partners), Gimv (Euronext: GIMB), Legend Capital, NeoMed Management, RMM, Valiance Life Sciences and VI Partners. Additional information is available at www.jenavalve.com.
|
JenaValve Technology, Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used JenaValve Technology, Inc. email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact JenaValve Technology, Inc. customer service number call here 1-949-396-7500. To contact JenaValve Technology, Inc. customer service number in your country click here to find.
John Kilcoyne is the CEO of JenaValve Technology, Inc.. To contact John Kilcoyne email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.